Your Source for BioScience Venture Capital Data
  • SEARCH THE OnBioVC DATABASE:

  • OnBioVC NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon
  • Photobucket

  • FDA Registered Contract Manufacturer

Tandem Diabetes Care (San Diego, CA) focused on medical devices for diabetes closed a $13.1 Series B financing. Participants include Domain Associates, TPG Biotech and Second Technology Capital Investors.

Seattle Medical Technologies (Seattle, Washington) medical device company focused on diabetes, closed a $21M Series B financing. Participants include Canaan Partners, Skyline Venture Partners, Frazier Healthcare Ventures and Three Arch Partners.

enGene (Canada) protein drug delivery system targeting insulin regulation for diabetics, closed a $6.4M Series A financing. Participants include Saad Investments and Masa Life Science Ventures.

AgaMatrix (Salem, NH) maker of blood glucose monitoring systems that provide results to help users better manage their diabetes closed a $23.7M Series C financing. Participants include Ferrer Freeman & Co.

  Next Entries »

to top of page...